+44 (0) 207 727 1110  |  info@boston-medical-group.co.uk

Safe & effective

Treatment areas

Product outline

Production process

Cross-linking

Dextranomers

Ease of use

Safe & effective

Comparison

Before & after

The Hyaluronic acid used in our products is obtained through biosynthesis, making it safe and non-pathogenic for humans. With less than 0.025 IU/mg of endotoxins and less that 2 ppm of protein*, it exceeds the highest standard of purity for HA.

Revanesse & Redexis is completely free of all animal products, thus reducing the risk of an immunogenic reaction. The Hyaluronic acid is naturally integrated into the tissue keeping the skin looking healthy and natural.

Safety is our utmost concern.

The following tests have been conducted:

  • 4 weeks muscle implantation
  • Acute systemic injection test
  • Biocompatibility text
  • Cytotoxicity
  • Identification: pH, osmoality, residual BDDE, sterility
  • Intracutaneous reactivity
  • Mutagenicity
  • Protein
  • Reverse mutation assay
  • Tests for interactions with blood haemolysis test
  • Tests for local effect after implantation
  • Acute toxicity
  • Subchronic toxicity
  • 26 weeks biocompatibility and toxicity study

*Testing by AppTec Inc., Pennsylvania, USA

Home  |  Downloads  |  Manufactured by  |  Disclaimer    ©2010 Boston Medical Group Limited